230 filings
Page 5 of 12
8-K
uw9ehcl1
20 Feb 20
Other Events
9:12am
8-K
uneyy h5zrbvdu
12 Feb 20
Entry into a Material Definitive Agreement
4:55pm
8-K
1uq5z
12 Feb 20
Hepion Pharmaceuticals Announces Advancement to Third Dose Level in Ongoing Multiple
4:24pm
8-K
ka9ufli40xt1yck
7 Feb 20
Regulation FD Disclosure
4:46pm
8-K
jcvgajq6ap is
28 Jan 20
Other Events
4:24pm
8-K
uy14l
9 Jan 20
Hepion Pharmaceuticals Presents Update on CRV431 Nonclinical Studies at NASH-TAG 2020 Conference
12:00am
8-K
t25g2c rz
6 Jan 20
Hepion Pharmaceuticals Announces Publication inExpert Opinion on Investigational Drugs
4:23pm
8-K
42699di6pytloie3m
11 Dec 19
Other Events
1:26pm
8-K
3ns91s 2cz5og5m0
4 Dec 19
Hepion Pharmaceuticals Announces Canadian Research Team’s Academic Appointments
12:00am
8-K
z975yioemmny5zp2
3 Dec 19
Regulation FD Disclosure
4:15pm
8-K
63rxkhs6dieh
20 Nov 19
Other Events
9:27pm
8-K
xq59xyd
8 Nov 19
Hepion Pharmaceuticals to Present at The Liver MeetingÒ 2019
12:00am
8-K
pjwtz8gz 3i
7 Nov 19
Other Events
12:55pm
8-K
inmbp1mdt6fzp1
23 Oct 19
Hepion Pharmaceuticals to Present on CRV431 at the 3rd Annual NASH Summit
4:29pm
8-K
7n1n c9gg
16 Oct 19
Hepion Pharmaceuticals Announces Publication of Data Highlighting CRV431’s Potential as a Treatment for Chronic Liver Diseases
4:54pm
8-K
ihoksg7b43c5 puv3
10 Oct 19
World-Renowned Liver Disease Expert, Dr. Stephen Harrison, Joins Hepion Pharmaceuticals as Consultant Medical Director
11:33am
8-K
krcl59xivtz6f ti937n
8 Oct 19
Departure of Directors or Certain Officers
4:15pm
8-K
i20p6z4f
3 Oct 19
Hepion Pharmaceuticals Strengthens Management Team with Three Key Promotions
4:20pm
8-K
02delqj94md oh
4 Sep 19
Hepion Pharmaceuticals to Present at the H. C. Wainwright 21st Annual Global Investment Conference
11:46am
8-K
n5f4lrl51b8esn
3 Sep 19
Other Events
4:39pm